Daiwa Securities Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Daiwa Securities Group’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-135	Closed	-$4K	–	1196
2025 Q4	$4K	Hold	135	–	–	﹤0.01%	1249
2025 Q3	$4K	Sell	135 -50	-27%	-$1.29K	﹤0.01%	1217
2025 Q2	$4K	Hold	185	–	–	﹤0.01%	1162
2025 Q1	$5K	Hold	185	–	–	﹤0.01%	1125
2024 Q4	$7K	Hold	185	–	–	﹤0.01%	1141
2024 Q3	$9K	Buy	185 +31	+20%	+$1.36K	﹤0.01%	1134
2024 Q2	$6K	Sell	154 -40	-21%	-$1.66K	﹤0.01%	1184
2024 Q1	$9K	Hold	194	–	–	﹤0.01%	1168
2023 Q4	$12K	Hold	194	–	–	﹤0.01%	1157
2023 Q3	$9K	Hold	194	–	–	﹤0.01%	1130
2023 Q2	$11K	Hold	194	–	–	﹤0.01%	1134
2023 Q1	$7K	Hold	194	–	–	﹤0.01%	1131
2022 Q4	$5K	Buy	194 +29	+18%	+$842	﹤0.01%	1154
2022 Q3	$5K	Hold	165	–	–	﹤0.01%	1159
2022 Q2	$6K	Hold	165	–	–	﹤0.01%	1157
2022 Q1	$6K	Hold	165	–	–	﹤0.01%	1157
2021 Q4	$4K	Hold	165	–	–	﹤0.01%	1211
2021 Q3	$3K	Buy	165 +76	+85%	+$1.49K	﹤0.01%	1208
2021 Q2	$2K	Hold	89	–	–	﹤0.01%	1131
2021 Q1	$2K	Hold	89	–	–	﹤0.01%	1133
2020 Q4	$2K	Sell	89 -176	-66%	-$3.42K	﹤0.01%	1109
2020 Q3	$5K	Hold	265	–	–	﹤0.01%	1086
2020 Q2	$4K	Hold	265	–	–	﹤0.01%	1116
2020 Q1	$4K	Hold	265	–	–	﹤0.01%	1111
2019 Q4	$5K	Sell	265 -31	-10%	-$595	﹤0.01%	1103
2019 Q3	$6K	Hold	296	–	–	﹤0.01%	1061
2019 Q2	$6K	Buy	296 +42	+17%	+$878	﹤0.01%	1079
2019 Q1	$5K	Hold	254	–	–	﹤0.01%	1078
2018 Q4	$5K	Hold	254	–	–	﹤0.01%	1052
2018 Q3	$5K	Hold	254	–	–	﹤0.01%	1079
2018 Q2	$4K	Hold	254	–	–	﹤0.01%	1104
2018 Q1	$5K	Buy	+254	New	+$4.78K	﹤0.01%	1072

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Daiwa Securities Group's AMPH Position: Q1 2026 in Review

Daiwa Securities Group sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 135 shares — an estimated $4K sold.

Daiwa Securities Group first reported a position in AMPH in Q1 2018 and held it in 32 quarters. The position peaked at $12K in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Daiwa Securities Group reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 135 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $4K.
Daiwa Securities Group first reported a position in Amphastar Pharmaceuticals in Q1 2018 and held it in 32 quarters.
Daiwa Securities Group's Amphastar Pharmaceuticals position peaked at $12K in Q4 2023.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.